AZAHAR Study To Describe Anifrolumab in a Real-World Setting

Trial Identifier: D3461R00080
Sponsor: AstraZeneca
Start Date: February 2025
Primary Completion Date: March 2025
Study Completion Date: March 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain Barcelona, Spain
Spain Granada, Spain
Spain Jaen, Spain
Spain Leon, Spain
Spain L'Hospitalet de Llobregat, Spain
Spain Madrid, Spain
Spain Malaga, Spain
Spain Merida, Spain
Spain Mostoles, Spain
Spain Murcia, Spain
Spain Sevilla, Spain
Spain Toledo, Spain
Spain Valladolid, Spain